Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

McIntosh JG, Minshall J, Saya S, Bickerstaffe A, Hewabandu N, Qama A, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e836-e842. doi: 10.3399/bjgp19X706841. Print 2019 Dec.

PMID:
31636127
2.

The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.

Harty EC, McIntosh JG, Bickerstaffe A, Hewabandu N, Emery JD.

Fam Pract. 2019 Nov 18;36(6):730-735. doi: 10.1093/fampra/cmz029.

PMID:
31237329
3.

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening

Kim GY, Walker JG, Bickerstaffe A, Hewabandu N, Pirotta M, Flander L, Jenkins M, Emery JD.

Aust J Gen Pract. 2018 Mar;47(3):139-145. doi: 10.31128/AFP-04-17-4195.

4.

The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.

Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG; CRECRC, Jenkins M, Pirotta M, Walter FM, Emery JD.

BMC Med Inform Decis Mak. 2017 Jan 19;17(1):13. doi: 10.1186/s12911-017-0407-7.

Supplemental Content

Loading ...
Support Center